Generic Drug Research Priorities & Projects
Each year, FDA consults with industry and the public to develop a list of regulatory science initiatives on generic drugs in accordance with the Generic Drug User Fee Amendments (GDUFA). These priorities are discussed and developed in public meetings and workshops and result in several awarded projects each year.
Research Priorities
- FY 2020 GDUFA Science and Research Priorities (PDF – 107 KB)
- FY 2019 GDUFA Science and Research Priorities (PDF – 113 KB)
- FY 2018 GDUFA Science and Research Priorities (PDF – 113 KB)
- FY 2017 GDUFA Science and Research Priorities (PDF – 113 KB)
- FY 2016 GDUFA Science and Research Priorities (PDF – 116 KB)
- FY 2015 GDUFA Science and Research Priorities (PDF – 113 KB)
- FY 2014 GDUFA Science and Research Priorities (PDF – 113 KB)
- FY 2013 GDUFA Science and Research Priorities (PDF – 113 KB)
GDUFA Regulatory Science Initiatives Public Workshops & Meetings
- FY 2020 Generic Drug Regulatory Science Initiatives Public Workshop (May 4, 2020)
- FY 2019 Generic Drug Regulatory Science Initiatives Public Workshop (May 1, 2019)
- FY 18 Generic Drug Research Public Workshop (May 24, 2018)
- FY 2017 Generic Drug Research Public Workshop (May 3, 2017)
- FY 2016 Regulatory Science Initiatives Part 15 Public Meeting (May 20, 2016)
- FY 2015 Regulatory Science Initiatives Part 15 Public Meeting (June 5, 2015)
- FY 2014 Regulatory Science Initiatives Part 15 Public Meeting (May 16, 2014)
- FY 2013 Regulatory Science Initiatives Part 15 Public Meeting (June 21, 2013)
Scientific Workshops & Meetings
- Upcoming: Advancing Innovative Science in Generic Drug Development Workshop (September 29-30, 2020)
- Complex Generic Drug Product Development Workshop (September 25-26, 2019)
- New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inhaled and Nasal Drug Products (January 9, 2018)
- FDA-DIA Workshop on Complex Generic Drug-Device Combination Products (October 9-10, 2018)
- Complex Generic Drug Product Development Workshop September 12-13, 2018
- Overcoming Barriers to the Development of, and Improving Patient Access to, Topical Dermatological Generic Drug Products (October 20, 2017)
- Demonstrating Equivalence of Generic Complex Drug Substances and Formulations: Advances in Characterization and In Vitro Testing (October 6, 2017)
- Leveraging Quantitative Methods and Modeling to Modernize Generic Drug Development and Review (October 2-3, 2017)
- Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation Workshop (May 19, 2016)
Awarded Projects
- FY 2019 Awarded GDUFA Science and Research Contracts and Grants (PDF – 182 KB)
- FY 2018 Awarded GDUFA Science and Research Contracts and Grants (PDF – 196 KB)
- FY 2017 Awarded GDUFA Science and Research Contracts (PDF – 98KB)
- FY 2016 Awarded GDUFA Science and Research Contracts and Grants (PDF – 98KB)
- FY 2015 Awarded GDUFA Science and Research Contracts and Grants (PDF – 143KB)
- FY 2014 Awarded GDUFA Science and Research Contracts and Grants (PDF – 98KB)
- FY 2013 Awarded GDUFA Science and Research Contracts and Grants (PDF – 98KB)
GDUFA Implementation
- Bi-Annual Industry Regulatory Science Group Meeting - February 10, 2020
- Bi-Annual Industry Regulatory Science Work Group Meeting – September 17, 2019
- Bi-Annual Industry Regulatory Science Work Group Meeting – February 25, 2019
- Bi-Annual Industry Regulatory Science Work Group Meeting – November 1, 2018
- Bi-Annual Industry Regulatory Science Work Group Meeting – April 10, 2018